Pfizer recalls Levoxyl (levothyroxine sodium tablets
- Published
- 28 Oct 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
- Brand / company
- Pfizer
- Codes / lots
- Lot # 24W06, Exp: 11/30/2026 | Lot # 24W07, Exp: 11/30/2026
- Distribution
- US Nationwide and Puerto Rico
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 28 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.